TY - JOUR AU - Yang Q. AU - Wang J. AU - Chasman D. AU - Hofman A. AU - Gudnason V. AU - Harris T. AU - Ridker P. AU - Salvi E. AU - Kutalik Z. AU - Bochud M. AU - Barlassina C. AU - Staessen J. AU - Cusi D. AU - Kao W. AU - Uitterlinden A. AU - Kronenberg F. AU - Stengel B. AU - Johnson A. AU - Woodward Mark AU - Fox C. AU - Li M. AU - Lehtimaki T. AU - Eiriksdottir G. AU - Gansevoort R. AU - Hamet P. AU - Coresh J. AU - Gorski M. AU - Tin A. AU - Garnaas M. AU - McMahon G. AU - Chu A. AU - Tayo B. AU - Pattaro C. AU - Teumer A. AU - Tremblay J. AU - Aspelund T. AU - Launer L. AU - Smith A. AU - Mitchell B. AU - O'Connell J. AU - Shuldiner A. AU - Freudenberger P. AU - Hofer E. AU - Schmidt H. AU - Schmidt R. AU - Holliday E. AU - Mitchell P. AU - de Boer I. AU - Li G. AU - Siscovick D. AU - Corre T. AU - Vollenweider P. AU - Waeber G. AU - Gupta J. AU - Kanetsky P. AU - Hwang S. AU - Olden M. AU - de Andrade M. AU - Atkinson E. AU - Kardia S. AU - Turner S. AU - Stafford J. AU - Ding J. AU - Liu Y. AU - Grallert H. AU - Meisinger C. AU - Muller-Nurasyid M. AU - Kramer B. AU - Kramer H. AU - Rosas S. AU - Nolte I. AU - Penninx B. AU - Snieder H. AU - M. Del Greco Fabiola AU - Franke A. AU - Nothlings U. AU - Lieb W. AU - Bakker S. AU - van der Harst P. AU - Dehghan A. AU - Franco O. AU - Rivadeneira F. AU - Sedaghat S. AU - Coassin S. AU - Haun M. AU - Kollerits B. AU - Paulweber B. AU - Aumann N. AU - Endlich K. AU - Pietzner M. AU - Volker U. AU - Rettig R. AU - Chouraki V. AU - Helmer C. AU - Lambert J. AU - Metzger M. AU - Lyytikainen L. AU - Raitakari O. AU - Parsa A. AU - Heid I. AU - Goessling W. AU - Kottgen A. AU - Boger C. AU - Chalmers J. AB -

Genome-wide association studies (GWASs) have identified multiple loci associated with cross-sectional eGFR, but a systematic genetic analysis of kidney function decline over time is missing. Here we conducted a GWAS meta-analysis among 63,558 participants of European descent, initially from 16 cohorts with serial kidney function measurements within the CKDGen Consortium, followed by independent replication among additional participants from 13 cohorts. In stage 1 GWAS meta-analysis, single-nucleotide polymorphisms (SNPs) at MEOX2, GALNT11, IL1RAP, NPPA, HPCAL1, and CDH23 showed the strongest associations for at least one trait, in addition to the known UMOD locus, which showed genome-wide significance with an annual change in eGFR. In stage 2 meta-analysis, the significant association at UMOD was replicated. Associations at GALNT11 with Rapid Decline (annual eGFR decline of 3 ml/min per 1.73 m2 or more), and CDH23 with eGFR change among those with CKD showed significant suggestive evidence of replication. Combined stage 1 and 2 meta-analyses showed significance for UMOD, GALNT11, and CDH23. Morpholino knockdowns of galnt11 and cdh23 in zebrafish embryos each had signs of severe edema 72 h after gentamicin treatment compared with controls, but no gross morphological renal abnormalities before gentamicin administration. Thus, our results suggest a role in the deterioration of kidney function for the loci GALNT11 and CDH23, and show that the UMOD locus is significantly associated with kidney function decline.Kidney International advance online publication, 10 December 2014; doi:10.1038/ki.2014.361.

AD - 1] Department of Genetic Epidemiology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany [2] Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
1] Division of Nephrology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA [2] NHLBI's Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA.
Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Department of Public Health Services, Loyola Medical Center, Loyola University Chicago, Maywood, Illinois, USA.
Center for Biomedicine, European Academy of Bozen/Bolzano (EURAC), affiliated to the University of Lubeck, Bolzano, Italy.
Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.
George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.
Centre de recherche du Centre hospitalier de l'Universite de Montreal, University of Montreal, Montreal, Quebec, Canada.
CHUM Research Center- Technopole Angus, Montreal, Quebec, Canada.
1] Icelandic Heart Association, Research Institute, Kopavogur, Iceland [2] University of Iceland, Reykjavik, Iceland.
Icelandic Heart Association, Research Institute, Kopavogur, Iceland.
Intramural Research Program, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, Maryland, USA.
1] Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA [2] Geriatric Research and Education Clinical Center, Veterans Administration Medical Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
1] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA [2] Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland, USA.
Institute of Molecular Biology and Biochemistry, Medical University Graz, Graz, Austria.
Department of Neurology, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Graz, Austria.
Department of Neurology, Medical University Graz, Graz, Austria.
Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, CReDITSS, HMRI, Callaghan, New South Wales, Australia.
Centre for Vision Research, Westmead Millennium Institute, University of Sydney, Westmead Hospital, Sydney, New South Wales, Australia.
University of Washington, Seattle, Washington, USA.
Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA.
1] Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA [2] New York Academy of Medicine, New York, New York, USA.
1] Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland [2] Department of Medical Genetics, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland.
Internal Medicine Department, Lausanne University Hospital, Lausanne, Switzerland.
Perelman School of Medicine at the University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics.
NHLBI's Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA.
1] Department of Genetic Epidemiology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany [2] NHLBI's Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA.
1] NHLBI's Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA [2] Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Mayo Clinic, Rochester, Minnesota, USA.
University of Michigan, Ann Arbor, Michigan, USA.
Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Health Science, University of Milano, Milano, Italy.
1] Department of Health Science, University of Milano, Milano, Italy [2] Division of Nephrology, San Paolo Hospital, Milano, Italy.
1] Department of Epidemiology, Maastricht University, Maastricht, The Netherlands [2] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
1] Institute of Epidemiology II, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany [2] Research Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany [3] German Center for Diabetes Research, Neuherberg, Germany.
Institute of Epidemiology II, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany.
1] DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany [2] Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany [3] Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig-Maximilians-Universitat, Munich, Germany [4] Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-Universitat, Munich, Germany.
University Medical Centre Mannheim, 5th Department of Medicine, University of Heidelberg, Mannheim, Germany.
Joslin Diabetes Center and Beth Israel Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
1] Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands [2] Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology (FA40), University Medical Center Groningen, Groningen, The Netherlands.
1] Department of Psychiatry/EMGO Institute/Neuroscience Campus, VU University Medical Centre, Amsterdam, The Netherlands [2] EMGO Institute Vumc, NESDA, Amsterdam, The Netherlands.
Institute of Clinical Molecular Biology, Kiel, Germany.
1] Popgen Biobank, University Hospital Schleswig-Holstein, Kiel, Germany [2] Section for Epidemiology, Institute for Experimental Medicine, Christian-Albrechts-University of Kiel, Kiel, Germany.
Institute of Epidemiology and Biobank popgen, Christian-Albrechts University, Kiel, Germany.
University Medical Center Groningen, Department of Nephrology, University of Groningen, Groningen, The Netherlands.
University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands.
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Division of Genetic Epidemiology, Innsbruck Medical University, Innsbruck, Austria.
First Department of Internal Medicine, Paracelsus Private Medical University Salzburg, Salzburg, Austria.
Department SHIP/KEF, Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Institute of Anatomy and Cell Biology, University Medicine Greifswald, Greifswald, Germany.
Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Institute of Physiology, University of Greifswald, Greifswald-Karlsburg, Germany.
Inserm, U744, Institut Pasteur de Lille, Universite Lille-Nord de France, CHR&U de Lille, Service d'epidemiologie regional, CHRU, Lille, France.
Inserm, U897, Universite Bordeaux 2, ISPED, ISPED, Universite Bordeaux 2, Bordeaux, France.
Inserm, U744, Institut Pasteur de Lille, Universite Lille-Nord de France, Institut Pasteur, Lille, France.
Inserm, U1018, University Paris-Sud, CESP Team 10, Villejuif, France.
Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
1] Department of Clinical Physiology, Turku University Hospital, Turku, Finland [2] Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
NHLBI Cardiovascular Epidemiology and Human Genomics Branch, Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA.
Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Epalinges, Switzerland.
1] Department of Genetic Epidemiology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany [2] Institute of Genetic Epidemiology, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany.
1] Divisions of Genetics and Gastroenterology, Department of Medicine, Brigham and Women's Hospital, and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA [2] Harvard Stem Cell Institute, Harvard University and Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
1] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA [2] Renal Division, Freiburg University Clinic, Germany, Freiburg, Germany.
1] NHLBI's Framingham Heart Study, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA [2] Department of Endocrinology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Department of Nephrology, University Hospital Regensburg, Regensburg, Germany. AN - 25493955 BT - Kidney International DA - -45793107251 DP - NLM ET - 2014/12/11 IS - 5 LA - Eng LB - UK
PDO N1 - Gorski, Mathias
Tin, Adrienne
Garnaas, Maija
McMahon, Gearoid M
Chu, Audrey Y
Tayo, Bamidele O
Pattaro, Cristian
Teumer, Alexander
Chasman, Daniel I
Chalmers, John
Hamet, Pavel
Tremblay, Johanne
Woodward, Marc
Aspelund, Thor
Eiriksdottir, Gudny
Gudnason, Vilmundur
Harris, Tamara B
Launer, Lenore J
Smith, Albert V
Mitchell, Braxton D
O'Connell, Jeffrey R
Shuldiner, Alan R
Coresh, Josef
Li, Man
Freudenberger, Paul
Hofer, Edith
Schmidt, Helena
Schmidt, Reinhold
Holliday, Elizabeth G
Mitchell, Paul
Wang, Jie Jin
de Boer, Ian H
Li, Guo
Siscovick, David S
Kutalik, Zoltan
Corre, Tanguy
Vollenweider, Peter
Waeber, Gerard
Gupta, Jayanta
Kanetsky, Peter A
Hwang, Shih-Jen
Olden, Matthias
Yang, Qiong
de Andrade, Mariza
Atkinson, Elizabeth J
Kardia, Sharon L R
Turner, Stephen T
Stafford, Jeanette M
Ding, Jingzhong
Liu, Yongmei
Barlassina, Cristina
Cusi, Daniele
Salvi, Erika
Staessen, Jan A
Ridker, Paul M
Grallert, Harald
Meisinger, Christa
Muller-Nurasyid, Martina
Kramer, Bernhard K
Kramer, Holly
Rosas, Sylvia E
Nolte, Ilja M
Penninx, Brenda W
Snieder, Harold
Fabiola Del Greco, M
Franke, Andre
Nothlings, Ute
Lieb, Wolfgang
Bakker, Stephan J L
Gansevoort, Ron T
van der Harst, Pim
Dehghan, Abbas
Franco, Oscar H
Hofman, Albert
Rivadeneira, Fernando
Sedaghat, Sanaz
Uitterlinden, Andre G
Coassin, Stefan
Haun, Margot
Kollerits, Barbara
Kronenberg, Florian
Paulweber, Bernhard
Aumann, Nicole
Endlich, Karlhans
Pietzner, Mike
Volker, Uwe
Rettig, Rainer
Chouraki, Vincent
Helmer, Catherine
Lambert, Jean-Charles
Metzger, Marie
Stengel, Benedicte
Lehtimaki, Terho
Lyytikainen, Leo-Pekka
Raitakari, Olli
Johnson, Andrew
Parsa, Afshin
Bochud, Murielle
Heid, Iris M
Goessling, Wolfram
Kottgen, Anna
Kao, W H Linda
Fox, Caroline S
Boger, Carsten A
Kidney Int. 2014 Dec 10. doi: 10.1038/ki.2014.361. N2 -

Genome-wide association studies (GWASs) have identified multiple loci associated with cross-sectional eGFR, but a systematic genetic analysis of kidney function decline over time is missing. Here we conducted a GWAS meta-analysis among 63,558 participants of European descent, initially from 16 cohorts with serial kidney function measurements within the CKDGen Consortium, followed by independent replication among additional participants from 13 cohorts. In stage 1 GWAS meta-analysis, single-nucleotide polymorphisms (SNPs) at MEOX2, GALNT11, IL1RAP, NPPA, HPCAL1, and CDH23 showed the strongest associations for at least one trait, in addition to the known UMOD locus, which showed genome-wide significance with an annual change in eGFR. In stage 2 meta-analysis, the significant association at UMOD was replicated. Associations at GALNT11 with Rapid Decline (annual eGFR decline of 3 ml/min per 1.73 m2 or more), and CDH23 with eGFR change among those with CKD showed significant suggestive evidence of replication. Combined stage 1 and 2 meta-analyses showed significance for UMOD, GALNT11, and CDH23. Morpholino knockdowns of galnt11 and cdh23 in zebrafish embryos each had signs of severe edema 72 h after gentamicin treatment compared with controls, but no gross morphological renal abnormalities before gentamicin administration. Thus, our results suggest a role in the deterioration of kidney function for the loci GALNT11 and CDH23, and show that the UMOD locus is significantly associated with kidney function decline.Kidney International advance online publication, 10 December 2014; doi:10.1038/ki.2014.361.

PY - 2015 SN - 1523-1755 (Electronic)
0085-2538 (Linking) SP - 1017 EP - 29 T2 - Kidney International TI - Genome-wide association study of kidney function decline in individuals of European descent: the CKDGen Consortium. VL - 87 ER -